Tumor necrosis factor-a promotes Staphylococcus aureus-induced osteomyelitis through downregulating endothelial nitric oxide synthase

被引:11
|
作者
Ma, Xin [1 ,2 ]
Xia, Wenyang [2 ]
Zong, Yang [2 ]
Jiang, Chaolai [2 ]
Shan, Haojie [2 ]
Lin, Yiwei [2 ]
Yin, Fuli [2 ]
Wang, Nan [3 ]
Zhou, Lihui [4 ]
Wen, Gen [2 ]
Zhou, Zubin [2 ]
机构
[1] Shanghai Univ Med & Hlth Sci, Dept Orthopaed Surg, Shanghai Peoples Hosp East 6, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200233, Peoples R China
[3] Zhengzhou Univ, Dept Emergency, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[4] Xiangshan First Peoples Hosp, Dept Orthopaed Surg, Ningbo 315700, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteomyelitis; Tumor necrosis factor-a; Staphylococcus aureus; Endothelial nitric oxide synthase; Oxidative stress; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; STEM-CELLS; ALPHA; EXPRESSION; MICRORNAS; MICE; INHIBITION; MECHANISMS; RNAS;
D O I
10.1016/j.jmii.2020.08.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Infections of Staphylococcus aureus (S. aureus) often result in osteomyelitis, which is the acute or chronic infections of the bone marrow or bones. TNF-a is long recognized as a key factor contributing to the pathogenesis of osteomyelitis, but little is known about the underlying molecular mechanism. Methods: Expression levels of TNF-a, and several candidate genes, including endothelial nitric oxide synthase (eNOS), known to be downregulated by TNF-a were analysed in MC3T3-E1 cells with S. aureus infection and osteomyelitis patient blood. MicroRNA(miR)-129-5p was predicted and experimentally verified to target eNOS. Alizarin red sulfate (ARS) and alkaline phosphatase (ALP) staining assays were conducted on MC3T3-E1 cells with S. aureus infection to assess the role of TNF-a/miR-129-5p/eNOS on mineralization defect. Results: TNF-a and miR-129-5p were upregulated while eNOS was downregulated in MC3T3-E1 cells with S. aureus infection and osteomyelitis patients, showing inversely correlated expression profiles. MiR-129-5p directly binds to the 30-UTR of eNOS mRNA to suppress eNOS expression in MC3T3-E1 cells. TNF-a blocker inhibited miR-129-5p and elevated eNOS expres-sion, likely contributing to rescued mineralization defect in S. aureus-infected MC3T3-E1 cells. During S. aureus infection, upregulated TNF-a increases endogenous miR-129-5p expression, which in turn inhibits eNOS, contributing to osteomyelitis. Conclusion: Our study thereby proposes a novel signalling cascade involving TNF-a/miR-129-5p/eNOS in the pathogenesis of osteomyelitis, which may also serve as therapeutic targets. Copyright 2020, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1018 / 1027
页数:10
相关论文
共 50 条
  • [1] Methicillin-resistant Staphylococcus aureus-induced vascular leakage is associated with excessive production of nitric oxide and vascular endothelial growth factor
    Perenlei Enkhbaatar
    Esechie Aimalohi
    Lillian Traber
    Collette Joncam
    Rhykka Connelly
    Matthias Lange
    Atsumori Hamahata
    D Herndon
    Daniel Traber
    Critical Care, 11 (Suppl 4):
  • [2] Nitric oxide and methicilin resistant Staphylococcus aureus-induced septic shock in sheep
    Jonkam, C.
    Enkhbaatar, P.
    Hamahata, A.
    Lange, M.
    Traber, L.
    Herndon, D.
    Traber, D.
    SHOCK, 2007, 27 : 65 - 65
  • [3] Cerivastatin prevents tumor necrosis factor-α-induced downregulation of endothelial nitric oxide synthase:: role of endothelial cytosolic proteins
    González-Fernández, F
    Jiménez, A
    López-Blaya, A
    Velasco, S
    Arriero, MM
    Celdrán, A
    Rico, L
    Farré, J
    Casado, S
    López-Farré, A
    ATHEROSCLEROSIS, 2001, 155 (01) : 61 - 70
  • [4] An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance
    Stenzel, W
    Soltek, S
    Miletic, H
    Hermann, MM
    Körner, H
    Sedgwick, JD
    Schlüter, D
    Deckert, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (01): : 27 - 36
  • [5] Aspirin prevents Escherichia coli lipopolysaccharide- and Staphylococcus aureus-induced downregulation of endothelial nitric oxide synthase expression in guinea pig pericardial tissue
    Arriero, MM
    de la Pinta, JC
    Escribano, M
    Celdrán, A
    Muñoz-Alameda, L
    García-Cañete, J
    Jiménez, AM
    Casado, S
    Farré, J
    López-Farré, A
    CIRCULATION RESEARCH, 2002, 90 (06) : 719 - 727
  • [6] Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor ox through estrogen receptor mediated system
    Sumi, D
    Hayashi, T
    Jayachandran, M
    Iguchi, A
    LIFE SCIENCES, 2001, 69 (14) : 1651 - 1660
  • [7] Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation
    Skjeflo, E. W.
    Christiansen, D.
    Fure, H.
    Ludviksen, J. K.
    Woodruff, T. M.
    Espevik, T.
    Nielsen, E. W.
    Brekke, O. L.
    Mollnes, T. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (05) : 905 - 918
  • [8] Tumor necrosis factor-α reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells
    Goodwin, Bonnie L.
    Pendleton, Laura C.
    Levy, Monique M.
    Solomonson, Larry P.
    Eichler, Duane C.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (02): : H1115 - H1121
  • [9] Suppression of inducible nitric oxide synthase and tumor necrosis factor-A expression by bisphenol a via nuclear factor-KB inactivation in macrophages.
    Kim, J
    Jeong, H
    TOXICOLOGICAL SCIENCES, 2003, 72 : 153 - 154
  • [10] Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor-driven cytotoxicity
    Mocellin, S
    Provenzano, M
    Rossi, CR
    Pilati, P
    Scalerta, R
    Lise, M
    Nitti, D
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6879 - 6886